Business Wire (May 9, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
578 people get MDGN articles and Market Currents by email alert.
Get email alerts on MDGN »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Mar 26, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Feb 8, 2013)
-
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 4, 2013)
-
Business Wire (Dec 6, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 14, 2012)
-
To learn more about Seeking Alpha Pro, click here.
There are no Transcripts on MDGN.
-
Business Wire (May 9, 2013)
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Mar 26, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Feb 8, 2013)
-
Business Wire (Jan 30, 2013)
-
Business Wire (Jan 4, 2013)
-
Business Wire (Dec 6, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 14, 2012)
-
Business Wire (Oct 16, 2012)
MDGN vs. ETF Alternatives
Company Description
Currently, there's no company description for MDGN.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 9, 9:57 AM Medgenics (MDGN): Q1 EPS of -$0.29 misses by $0.02. (PR) Comment! [Earnings, Breaking News, Healthcare]
-
- View all 5 replies
-
-
karatine14: what does it mean when it jumps down and up like that? are those actual trades people are making? or incorrect quote?
-
- View all 2 replies
-
-
-
- View all 3 replies
-
-
-
- View all 0 replies
-
prashAlpha
MDGN: 1st Subjects Enrolled In Ph-2a Clinical Trial Of EPODURE Biopumps To Treat Anemia In Patients With End-Stage Renal Disease On Dialysis - View all 0 replies
-
Scott Matusow
Didn't I suggest $MDGN when it was $7 a share? Closed all time high today at $15 a share.. I'm a luck box! Think I'll be wrong on $OMPI? - View all 17 replies
-
Scott Matusow: id have to look into ONCS. to be honest, I have been over focused in OMPI. Ya, I'm a luckbox, I take wild guesses and get lucky, believe me?
-
-
Scott Matusow
Don't expect a move like with $MDGN or " I will get rich overnight" the tech is exciting, no question, but remember, stocks are stocks - View all 0 replies
-
- View all 1 replies
-
-
Scott Matusow
I have a new feature article out on $MDGN, check it out at http://seekingalpha.com/a/elin - View all 0 replies
-
Scott Matusow
Short term target price opinion met on $MDGN this morning. Hit $9.65, 65 cents over my top target @ http://seekingalpha.com/a/ee5n #LUCKBOX - View all 4 replies
-
Scott Matusow: they absolutely do, and more so in the bio pharm segment than most because they show consistent PAST moves on catalysts.
-
LATEST REPLIES
-
- View all 5 replies
-
-
karatine14: what does it mean when it jumps down and up like that? are those actual trades people are making? or incorrect quote?
-
- View all 2 replies
-
-
-
- View all 3 replies
-
-
-
Scott Matusow
Didn't I suggest $MDGN when it was $7 a share? Closed all time high today at $15 a share.. I'm a luck box! Think I'll be wrong on $OMPI? - View all 17 replies
-
Scott Matusow: id have to look into ONCS. to be honest, I have been over focused in OMPI. Ya, I'm a luckbox, I take wild guesses and get lucky, believe me?
-
-
- View all 1 replies
-
-
Scott Matusow
Target nearly completed on $MDGN. said would see $9 on news, didnt think news today or this fast though! - View all 3 replies
-
Scott Matusow: u cant, its halted on Advisory committe recommendation approval.
-
garygallen: It came back early on pre-market @ about 42% higher than yesterdays close. MMs?, I backed off.
-
Scott Matusow
Short term target price opinion met on $MDGN this morning. Hit $9.65, 65 cents over my top target @ http://seekingalpha.com/a/ee5n #LUCKBOX - View all 4 replies
-
Scott Matusow: they absolutely do, and more so in the bio pharm segment than most because they show consistent PAST moves on catalysts.
-
-
Scott Matusow
News out on $MDGN, they got the orphan status and other stuff, check the news feeds, now watch it run! - View all 2 replies
-
drjbayer: Great News! Just barely got in on that. Those orphan status come quickly.
-
-
Scott Matusow
$MDGN moving back up, news was somewhat expected, but not during market hours, jeez! let's see what happens, interesting stuff. - View all 7 replies
-
-
-
Scott Matusow
Starting to think $MDGN could hit 10 the way its trading with a positive catalyst to bump it. - View all 5 replies
-
gafigal: Sadly, it moved too fast and me too slow. Missed that boat! Still, great call Scott!
-
-
Scott Matusow
$MDGN selling on news, heh, not what I thought, see, I am not always right, but company - View all 1 replies
-
-
Scott Matusow
My new article is out @ http://seekingalpha.com/a/ee5n $MDGN is my 'pop hard pick' I will be releasing a feature article on it tomorrow. - View all 6 replies
-
-